Clinical Trial Update: Hyperlipoproteinemia A as a Marker of Cardiovascular Risk in Patients With Stage 4 Chronic Kidney Disease

View source ↗

Summary

An update on a clinical study examining hyperlipoproteinemia A as a marker of cardiovascular risk in patients with stage 4 chronic kidney disease; the trial is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: CKD, Cardiovascular Diseases | Status: NOT_YET_RECRUITING